https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accounts-payable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accounts-payable-interest-bearing-interest-rate https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accounts-payable-other-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accounts-receivable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accounts-receivable-net https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accrued-employee-benefits https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accrued-income-taxes-payable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accrued-salaries-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/accumulated-depreciation https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/additional-paid-in-capital https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/allowance-for-loan-and-lease-loss-recovery-of-bad-debts https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/allowance-for-loan-and-lease-losses-provision-for-loss-net https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/amended-reports-10-k https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/amended-reports-10-q https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/aoci https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/assets-noncurrent https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/basic-shares https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/capital-expenditures https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/cash https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/cash-and-equivalents https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/cash-change https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/cash-flow-breakdown https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/common-stock-value https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/comprehensive-income https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/concentration-risk-percentage https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/concentration-risk-percentage-1 https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/cost-of-revenue https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/cumulative-earnings-deficit https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/current-assets https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/current-liabilities https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/customer-advances-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-income-taxes-and-other-liabilities-noncurrent https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deferred-taxes-acquisition-valuation-allowance-available-to-reduce-income-tax-expense https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/deposit-liability-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/depreciation https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/depreciation-and-amortization https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/depreciation-nonproduction https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/derivative-liabilities-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/diluted-shares https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/due-to-employees-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/due-to-related-parties-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/effect-of-exchange-rate-on-cash https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/eps https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/eps-basic https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-cost-of-sales https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-current-assets https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-current-liabilities https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-equity https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-gross-profit-loss https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-net-income-loss https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-noncurrent-assets https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/equity-method-investment-summarized-financial-information-noncurrent-liabilities https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/fair-value-assumptions-weighted-average-expected-dividend https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/financing-cash-flow https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/form-d-stocks https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/gain-loss-on-sale-of-equity-investments https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/general-and-administrative-expense https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/goodwill https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/gross-profit https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/income-tax https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-intangible-assets-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-loans-deferred-income https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/insider-transactions-preferred https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/insider-transactions-warrants https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/intangible-assets-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/interest-income-expense-net https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/interest-paid https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/interest-payable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/interest-payable-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/inventory https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/inventory-adjustments https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/inventory-finished-goods https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/inventory-raw-materials https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/inventory-work-in-process https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/inventory-write-down https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/investing-cash-flow https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/investments-in-affiliates-subsidiaries-associates-and-joint-ventures https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/liabilities-noncurrent https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/loans-payable-to-bank-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/long-term-loans-from-bank https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/minority-interest https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/minority-interest-ownership-percentage-by-parent https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/net-change-in-cash https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/net-income https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/net-income-loss-allocated-to-general-partners https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/notes-payable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/notes-receivable-net https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/oci-net-of-tax-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/operating-cash-flow https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/operating-expenses https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/operating-income https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-employee-related-liabilities-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-expenses https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-income https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-intangible-assets-net https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-loans-payable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-loans-payable-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/other-loans-payable-long-term https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/payments-for-proceeds-from-loans-receivable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/pretax-income https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-loans https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-other-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-payments-to-minority-shareholders https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-repayments-of-other-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-repayments-of-other-long-term-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-repayments-of-short-term-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-sale-of-equity-method-investments https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-sale-of-other-assets https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/profit-loss https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/property-plant-equipment https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/public-float https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/repayments-of-other-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/repayments-of-other-long-term-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/research-and-development https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/restructuring-settlement-and-impairment-provisions https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/retained-earnings https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/revenue https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sales-revenue-net https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-10-12b https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-10-k https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-10-q https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-10ksb https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-10qsb https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-10sb12b https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-15-12g https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-25 https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-8-k https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-certnys https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-def-14a https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-def-14c https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-defa14a https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-ntn-10k https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-ntn-10q https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/secondary-offerings-form-aw https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/selling-expense https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/shareholders-equity https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/shares-authorized https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/shares-issued https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/short-term-borrowings https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-issued-shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-issued-shares-issued-shares-employee-stock-ownership-plan https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-option-plan-expense https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/subsidiary-of-limited-liability-company-or-limited-partnership-ownership-interest https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/tax-reconciliation-deductions-other https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/tax-reconciliation-tax-settlements-foreign https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/total-assets https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/utb-resulting-in-net-operating-loss-carryforward https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/valuation-allowance-for-impairment-of-recognized-servicing-assets-provisions https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/aoxing-pharmaceutical-company-inc/write-off-of-inventory